Core Insights - Thermo Fisher Scientific Inc. has launched the Olink® Target 48 Neurodegeneration panel aimed at enhancing research in neurodegenerative diseases [1] - The panel is a high-performance, targeted proteomics immunoassay designed to meet the growing demand for translational biomarkers in the context of diseases like Alzheimer's, multiple sclerosis, and Parkinson's [1] - There is an increasing prevalence of neurodegenerative diseases, which is driving the need for scalable research solutions in the clinical pipeline [1]